Doctor Care Anywhere Group has reported H1 2026 revenue of £20.4 million, up 6.3%, EBITDA of £2.6 million, up 27.1%, net profit of £600,000, up 28.5%, and free cash flow more than doubled to £1.5 million; the results include £900,000 contribution from the May 2026 acquisition of weight management business DCA Medicspot.

Doctor Care Anywhere Group PLC (ASX: DOC) is a London-headquartered telehealth provider founded in 2013 and listed on the Australian Securities Exchange, employing approximately 610 people and operating across the UK and the Republic of Ireland. The group provides virtual GP, mental health, physiotherapy, specialist care pathways and health assessments through insurer, corporate and direct-to-consumer channels.

AXA PPP Healthcare is the group's primary insurer partner, previously extending an $18 million secured loan to the company. H1 2026 consultation volumes reached 354,900, up 1.4%, with 74% of consultations from repeat patients. Cash at end June stood at £7.7 million, up 60.3% year on year.

The structural driver is deliberate diversification away from insurer dependency. Subscription revenue grew from 7.1% to 10.8% of total revenue, reflecting the DCA Medicspot acquisition and the continued shift toward direct-to-consumer channels. 

The Ramsay Health Care UK partnership, giving Ramsay patients access to self-pay virtual GP appointments with secondary care referrals into Ramsay hospitals, deepens the group's embedded position within private hospital networks rather than insurer-mediated access. 

The weight management acquisition adds exposure to one of the UK private healthcare market's fastest-growing segments, where GLP-1 medication demand has created significant direct-to-consumer prescribing and monitoring needs that telehealth platforms are well positioned to serve.

The repeat patient rate of 74% is the metric that matters most for long-term revenue quality. A telehealth model where three quarters of consultations are from returning patients is fundamentally more defensible than one dependent on new patient acquisition, and the improvement from 72.9% in H1 2025 signals a platform generating genuine clinical continuity rather than episodic access.

For the sector, DCA's results confirm that profitable UK telehealth at scale requires two structural conditions simultaneously: insurer distribution for volume and direct-to-consumer channels for margin, and the group is now delivering both.

Source: tradingview.com / morningstar.com.au / doctorcareanywhere.com / smallcaps.com.au